Cardiac Anxiety, CBT, Exposure, Myocardial Infarction
Conditions
Brief summary
Myocardial infarction (MI) is one of the leading cause s of health loss globally, representing a large proportion of general disability. Anxiety and depression occur in 20-30 percent of patients following MI and have been identified as risk factors for recurrent adverse cardiac event. The purpose of our this study is to develop and evaluate a disease specific cognitive behavioral therapy (C BT) protocol to reduce cardia anxiety, depression, increase physical inactivity and quality of life (Q oL) in patients following MI
Detailed description
The study will include 30 patients. The MI-specific CBT lasts for 8 weeks and is therapist guided and delivered via internet via a secure digital platform by licensed psychologists expertise in CBT for cardiac disease or final year psychologist under supervision. During treatment, the psychologists will have direct access to a cardiologist assigned to the project and treatments are conducted in close interdisciplinary collaboration to ensure patient safety
Interventions
BEHAVIORALMI-CBT
Education of MI and common reactions, Interoceptive exposure, Exposure in-vivo, Behavioral activation, Relapse prevention
Sponsors
Karolinska Institutet
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
( - )MI ≥ 6 months before assessment ( - )Age 18-75 years endorsed cardiac anxiety that leads to significant distress or interferes with daily life (Cardiac Anxiety Questionnaire (CAQ); score ≥20) ( - ) On optimal medical treatment ( - )Able to read and write in Swedish.
Exclusion criteria
( - ) heart failure with severe systolic dysfunction (ejection fraction ≤ 35%) ( - ) significant valvular disease ( - ) planned coronary artery bypass surgery or other invasive therapy ( - ) other severe medical illness ( - )any medical restriction to physical exercise ( - )severe psychiatric disorder, severe depression, or risk of suicide ( - )alcohol dependency
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| 12-Item Short-Form Health Survey (SF-12) | Baseline | General quality of life, with a score ranging from 0 to 100. A higher score indicating a better quality of life. General quality of life, with a score ranging from 0 to 100. A higher score indicating a better quality of life. General quality of life, with a score ranging from 0 to 100. A higher score indicating a better quality of life. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Cardiac anxiety questionnaire | Baseline | Measure of cardiac anxiety, fear, avoidance and attention. The score ranges between 0 and 72, with a greater score indicating elevated cardiac anxiety. |
| Body Sensation Questionnaire | Baseline | Fear of bodily symptoms, score ranging from 0 to 72 . Higher scores indicate more fear of body sensations. Fear of bodily symptoms, score ranging from 0 to 72 . Higher scores indicate more fear of body sensations. Fear of bodily symptoms, score ranging from 0 to 72 . Higher scores indicate more fear of body sensations. |
| Generalized Anxiety Disorder 7-item | Baseline | General anxiety, score ranging from 0-21, with a higher score indicating more anxiety and worry. |
| The Godin Leisure-time Exercise | Baseline | Level of physical activity. The participant rate numbers of time per week that they engage in physical activity. The numb ers are the categorized in to low, moderate, and high levels of physical activity. |
| Tampas Scale for Kinesophobia-Heart version | Baseline | Fear of physical activity. The total score varies between 17 and 68, with higher values indicating more severe kinesiophobia. |
| Patient Health Questionnaire-9 | Baseline | Measure of depression, score ranging 0 to 27 with a higher score indicating higher level of depression |
| Adverse events | 2 months from treatment | Potential adverse reactions to the treatment. Participants will be asked to report and rate the short- and long term discomfort of the adverse event on a scale from 0 ('did not affect me at all') and 3 ('affected me very negatively'). |
| Symptom Checklist (SCL) | Baseline | Measures frequency and severity of 16 cardiac-related symptoms. Scoring range from 0 to 64 for frequency with a greater score indicating more frequent symptoms, and from range from 0 to 48 for severity, with a greater score indicating more severe symptoms |
| Perceived stress scale (4-item version) | Baseline | Stress reactivity. A greater score indicate more perceived stress. |
| Insomnia Severity Index | Baseline | Measurement of sleep |
| The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) | Baseline | Measure of post traumatic stress, score ranging from 0-80, with a higher score indicating more post traumatic stress. |
| Client satisfaction Questionnaire | Baseline | Treatment satisfaction, score ranging from 0 to 32, with a higher score indication more satisfaction with the treatment. |
Countries
Sweden
Outcome results
None listed